The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis.

Eur Arch Otorhinolaryngol

Department of Otolaryngology, Head and Neck Surgery, Cancer Research Institute, Research Institute for Medical Sciences, Chungnam National University School of Medicine, 640 Daesa-Dong, Chung-Gu, Daejeon, 301-040, South Korea.

Published: March 2012

AI Article Synopsis

  • The study aims to examine differences in characteristics between patients with papillary thyroid carcinoma (PTC) who also have chronic lymphocytic thyroiditis (CLT) and those who do not.
  • Out of 195 PTC patients, 56 (28.7%) had CLT, and findings revealed that CLT patients were generally younger, predominantly female, and had smaller tumors with less capsular invasion and lower rates of lymph node metastasis.
  • Age and gender were identified as significant independent factors affecting prognosis in PTC patients with CLT, emphasizing the association between CLT and PTC.

Article Abstract

The goal of this study is to determine the clinicopathologic differences in patients with papillary thyroid carcinoma (PTC) with or without chronic lymphocytic thyroiditis (CLT). We reviewed the medical records of 195 consecutive PTC patients who underwent total thyroidectomy and bilateral central lymph node dissection from April 2008 to March 2010. The differences in clinicopathologic factors, such as age, gender, size of primary tumor, perithyroidal invasion, lymphovascular invasion, capsular invasion, and central lymph node (CLN) metastasis, were analyzed in PTC patients with or without CLT. Among 195 patients, 56 (28.7%) had co-existing CLT. Patients with CLT had the following characteristics as compared to patients without CLT: significantly younger, female predominance, smaller tumor size, and lower incidence of capsular invasion (p = 0.038, 0.006, 0.037, and 0.026, respectively). Also, patients with CLT (12.5%) had a significantly lower incidence of CLN metastases than patients without CLT (28.1%; p = 0.025) based on univariate analysis. Moreover, multivariate analysis showed that younger age (p = 0.042, odds ratio = 1.033) and female gender (p = 0.012, odds ratio = 6.865) are independent clinical factors in patients with CLT compared to patients without CLT. CLT was shown to be commonly associated with PTC. Compared to patients with PTC without CLT, patients with CLT were younger with a female predominance, which are the most important and well-known prognostic variables for thyroid cancer mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-011-1732-6DOI Listing

Publication Analysis

Top Keywords

patients clt
32
patients
12
clt
12
compared patients
12
clinicopathologic differences
8
papillary thyroid
8
thyroid carcinoma
8
chronic lymphocytic
8
lymphocytic thyroiditis
8
ptc patients
8

Similar Publications

Objectives: To assess the effect of treatment on haemostatic parameters in patients with early rheumatoid arthritis (RA).

Methods: Patients with newly diagnosed RA started methotrexate and were randomised to additional conventional treatment, certolizumab pegol, abatacept or tocilizumab. Several biomarkers for haemostasis were analysed including parameters of the two global haemostatic assays-overall haemostatic potential (OHP) and endogenous thrombin potential (ETP), as well as single haemostatic factors-fibrinogen, prothrombin fragment 1+2 (F1+2), D-dimer, thrombin activatable fibrinolysis inhibitor (TAFI) and clot lysis time (CLT) in 24 patients at baseline, 12 and 24 weeks after the start of the treatment.

View Article and Find Full Text PDF

Exercise stress test-induced hypofibrinolysis and changes in circulating levels of several interleukins have been observed in aortic stenosis (AS). However, it is unknown whether the pattern of exercise-induced changes in oxidative stress differs between AS patients and controls and if the differences are associated with changes in fibrinolysis and inflammation. We studied 32 asymptomatic patients with moderate-to-severe AS and 32 controls of similar age, sex, and body mass index.

View Article and Find Full Text PDF

Influence of HLA mismatch between donors and recipients on postoperative outcomes in cadaveric lung transplantation.

Gen Thorac Cardiovasc Surg

December 2024

Department of Thoracic Surgery, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Objectives: Generally, HLA matching between donors and recipients is not performed in lung transplantation (LTx). Therefore, whether HLA mismatch between donors and recipients (D/R mismatch) influences postoperative outcomes after LTx remains uncertain. In this study, we investigated the influence of D/R mismatch on postoperative outcomes after cadaveric LTx (CLT).

View Article and Find Full Text PDF
Article Synopsis
  • NMOSD is a rare autoimmune disease affecting the CNS, and this study is the first Phase I clinical trial in Chinese patients testing the safety and efficacy of a new drug called BAT4406F, an anti-CD20 monoclonal antibody.
  • The study involved 15 patients who received different doses of BAT4406F, with results showing no dose-limiting toxicities and mostly mild side effects, indicating a favorable safety profile.
  • The drug demonstrated effective B-cell depletion, important for treating NMOSD, with a nonlinear pharmacokinetic profile and longer elimination half-life, suggesting promising therapeutic potential.
View Article and Find Full Text PDF

Environmental Life Cycle Assessment of a U.S. Hospital-based Radiology Practice.

Radiology

November 2024

From Koninklijke Philips NV, Amsterdam, the Netherlands (C.L.T., M.V.G., S.N., C.M., J.G., O.S., S.T.); and Department of Radiology, Vanderbilt University Medical Center, 1211 Medical Center Dr, VUH 1145, Nashville, TN 37212 (D.P., R.A.O., D.E.C., J.R.S.).

Background Climate change, driven primarily by human-induced greenhouse gas (GHG) emissions, poses major risks to human health. Health care contributes 8.5% of GHG emissions in the United States.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!